OTTAWA, ONTARIO, Mar 19, 2012 (MARKETWIRE via COMTEX) -- The issue: Health Canada is informing Canadians that Apotex Incorporated is conducting a voluntary recall of one lot of Apo-Ramipril 5mg ...
An earlier study in 45- to 80-year-old Indian patients with 1 CVD risk factor [7] also explored the polypill therapy, this one consisting of 12.5 mg thiazide, 50 mg atenolol, 5 mg ramipril, 20 mg ...
This document corrects and replaces the press release that was sent today at 11:52 AM EDT. The Lot number should have read JR2178. The issue: Health Canada is informing Canadians that Apotex ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback